- Home
- CPAY vs DXCM Comparison
CPAY vs DXCM Comparison
Compare CPAY & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPAY | DXCM |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 25.9B |
| IPO Year | 2010 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CPAY | DXCM |
|---|---|---|
| Price | $306.18 | $67.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 21 |
| Target Price | ★ $369.64 | $86.86 |
| AVG Volume (30 Days) | 532.5K | ★ 4.7M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5.04 | ★ 7.75 |
| EPS | ★ 14.72 | 1.80 |
| Revenue | $4,314,608,000.00 | ★ $4,515,900,000.00 |
| Revenue This Year | $15.86 | $17.38 |
| Revenue Next Year | $15.55 | $12.76 |
| P/E Ratio | ★ $20.99 | $37.55 |
| Revenue Growth | 11.27 | ★ 14.21 |
| 52 Week Low | $252.84 | $54.11 |
| 52 Week High | $400.81 | $93.25 |
Technical Indicators
Market Signals| Indicator | CPAY | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 58.27 |
| Support Level | $301.00 | $65.56 |
| Resistance Level | $316.01 | $68.18 |
| Average True Range (ATR) | 7.17 | 1.63 |
| MACD | -1.16 | 0.03 |
| Stochastic Oscillator | 27.90 | 44.86 |
Price Performance
Historical ComparisonAbout CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.